Madrigal Pharmaceuticals stock maintains bullish momentum, trading near $520 resistance

Madrigal Pharmaceuticals stock maintains bullish momentum, trading near $520 resistance
Madrigal Pharmaceuticals up 1.41% today

Madrigal Pharmaceuticals will participate in the inaugural SOLAR Conference in San Juan, Puerto Rico.

Highlights

  • MDGL maintains a bullish structure, trading above key moving averages with strong annual uptrend confirmed by recent price action.
  • Short- and medium-term momentum signals are mixed; while the Awesome Oscillator and weekly indicators suggest continued strength, several overbought readings signal a potentially overextended move.
  • Price is expected to consolidate between $517.00 and $527.00 next week, with a breakout above $527.00 targeting $615.00, while a decline below $517.00 appears less likely given current signals.

The company will host a product theater presented by Kris Kowdley, MD and Rashmee Patil, MD. Details are available via the linked announcement.

Bullish trend sustained as price holds above key moving averages

MDGL is trading at $520.68, which is above the SMA-20 at $493.53, the SMA-50 at $509.44, and the SMA-200 at $494.19. This alignment supports a bullish structure across short-, medium-, and long-term trends. The Ichimoku Kijun level stands at $494.49, marking immediate support just beneath the current price. Near-term support is layered at the Ichimoku Kijun ($494.49) and the SMA-50 ($509.44), while key support emerges at the SMA-200 ($494.19). Immediate resistance is found just below the session high, with key resistance defined by the SMA-20 ($493.53) and more distantly by the 52-week high of $615.00.

Overbought risks emerging as upside momentum reaches weekly peak

Momentum on D1 is neutral, with MACD signaling little conviction and ADX at 12.96 also confirming a lack of strong trend. RSI reads 56.11, suggesting moderate bullishness, but both Stoch RSI and BBP indicate overbought conditions and strong buyer dominance intraday. CCI at 88.44 is positive but nearing overextended territory. Awesome Oscillator’s "Strong Buy" supports the upward tone. MDGL has risen $14.93, or 2.12%, over the past week, moving from a prev_week_close of $505.75. The stock is now at the very top of its weekly range, with weekly volatility at 7.09%. The weekly performance shows strong upward momentum, but the convergence of overbought signals suggests the move may be overextended. In today's session, MDGL is up 1.41%, reflecting renewed short-term buying interest.

Range-bound outlook favored as upside probability outweighs downside risks

Looking ahead, the expected price range for the coming week is $517.00 to $527.00, reflecting the recent high-volatility band and consistent with the current price near the top quartile of its 52-week performance. The probability of an upward move is very high (more than 80%), as indicated by bullish signals from RSI-W1, MACD-W1, and MA-50-W1, while a decline is less likely. The baseline scenario anticipates sideways movement between $517.00 and $527.00. A bullish scenario could see a break above $527.00, with potential extension toward the yearly high of $615.00 if momentum persists. Conversely, a bearish scenario would require a drop below $517.00, exposing supports in the $509.00 to $494.00 range, though current signals make this less probable. This range sits well above the 52-week low of $278.00, underlining the strong annual uptrend.

Earlier, analysts noted that Madrigal Pharmaceuticals demonstrated ongoing bullish price momentum, though short-term technical signals were mixed and suggested potential for consolidation. Given current developments, traders should closely monitor for a decisive shift in momentum that could define the prevailing scenario for the next phase.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.